Ombitasvir + Paritaprevir + Ritonavir

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
Viekirax 12.5mg/75mg/50mg tabletsES EU GB
  • unknown Ombitasvir + Paritaprevir + Ritonavir
  • tablet Ombitasvir 12.5 mg + Paritaprevir 75 mg + Ritonavir 50 mg
  • tablet Ombitasvir 50 mg + Paritaprevir 12.5 mg + Ritonavir 75 mg
AbbVie Deutschland GmbH & Co. KG
Generic Viekirax 12.5mg/75mg/50mg tabletsGB12.5 mg / 75 mg / 50 mgAbbVie Ltd
ombitasvir + paritaprevir + ritonavirES12.5 mg / 75 mg / 50 mgAbbvie Deutschland Gmbh & Co. Kg
TECHNIVIECA
  • tablet Ombitasvir 12.5 mg + Paritaprevir 75 mg + Ritonavir 50 mg
ABBVIE CORPORATION

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.